Arcadia Biosciences (NASDAQ:RKDA) and Oriental Rise Holdings Limited Ordinary Shares (NASDAQ:ORIS) Critical Contrast

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) and Oriental Rise Holdings Limited Ordinary Shares (NASDAQ:ORISGet Free Report) are both small-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Earnings and Valuation

This table compares Arcadia Biosciences and Oriental Rise Holdings Limited Ordinary Shares”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Arcadia Biosciences $5.48 million 1.52 -$13.98 million ($4.28) -1.42
Oriental Rise Holdings Limited Ordinary Shares $16.75 million 2.82 $11.50 million N/A N/A

Oriental Rise Holdings Limited Ordinary Shares has higher revenue and earnings than Arcadia Biosciences.

Analyst Ratings

This is a breakdown of current ratings for Arcadia Biosciences and Oriental Rise Holdings Limited Ordinary Shares, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arcadia Biosciences 0 0 1 1 3.50
Oriental Rise Holdings Limited Ordinary Shares 0 0 0 0 0.00

Arcadia Biosciences currently has a consensus price target of $6.00, suggesting a potential downside of 1.48%. Given Arcadia Biosciences’ stronger consensus rating and higher probable upside, equities analysts clearly believe Arcadia Biosciences is more favorable than Oriental Rise Holdings Limited Ordinary Shares.

Profitability

This table compares Arcadia Biosciences and Oriental Rise Holdings Limited Ordinary Shares’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Arcadia Biosciences -110.61% -52.63% -34.57%
Oriental Rise Holdings Limited Ordinary Shares N/A N/A N/A

Institutional & Insider Ownership

17.7% of Arcadia Biosciences shares are held by institutional investors. 1.8% of Arcadia Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

About Oriental Rise Holdings Limited Ordinary Shares

(Get Free Report)

Oriental Rise Holdings Limited engages in planting, cultivating, processing, and selling processed tea in Mainland China. It offers processed white tea, black tea, and refined tea products to wholesale distributors and end-user retail customers. The company was incorporated in 2019 and is based in Ningde, China.

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.